ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

Autor Wrangle, John M, Velcheti, Vamsidhar, Patel, Manish R, Garrett-Mayer, Elizabeth, Hill, Elizabeth G, Ravenel, James G, Miller, Jeffrey S, Farhad, Mohammad, Anderton, Kate, Lindsey, Kathryn, Taffaro-Neskey, Michele, Sherman, Carol, Suriano, Samantha, Swiderska-Syn, Marzena, Sion, Amy, Harris, Joni, Edwards, Andie R, Rytlewski, Julie A, Sanders, Catherine M, Yusko, Erik C, Robinson, Mark D, Krieg, Carsten, Redmond, William L, Egan, Jack O, Rhode, Peter R, Jeng, Emily K, Rock, Amy D, Wong, Hing C, Rubinstein, Mark P
Vydáno v Lancet Oncol (2018)